Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.63
(
1.92%
)
Bitcoin
71,128.25
(
-0.16%
)
News Focus
News Focus
Post# of 30493
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 14132

Thursday, 02/02/2017 11:37:55 AM

Thursday, February 02, 2017 11:37:55 AM

Post# of 30493
I've always liked NVO and probably feel it could be priced right at these levels.

What's holding me back is that I feel there will be certain pharma sectors who'll have to correct their pricing models.

As an individual drug Humira would have to be number #1, and then closely followed the Diabetes, MS and Cancer groups.

The model is nothing besides silly.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now